New insider Fishman Peter L. claimed ownership of 48,162 units of Ordinary Shares (SEC Form 3)
$AMRN
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 10/23/2024 |
3. Issuer Name and Ticker or Trading Symbol
AMARIN CORP PLC\UK [ AMRN ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares(1) | 48,162 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Restricted Stock Units(2) | (3) | (4) | Ordinary Shares(1) | 2,600 | $0 | D | |
| Restricted Stock Units(2) | (5) | (4) | Ordinary Shares(1) | 8,400 | $0 | D | |
| Restricted Stock Units(2) | (6) | (4) | Ordinary Shares(1) | 12,500 | $0 | D | |
| Restricted Stock Units(2) | (7) | (4) | Ordinary Shares(1) | 22,534 | $0 | D | |
| Restricted Stock Units(2) | (8) | (4) | Ordinary Shares(1) | 5,000 | $0 | D | |
| Restricted Stock Units(2) | (9) | (4) | Ordinary Shares(1) | 110,000 | $0 | D | |
| Stock Option (Right to Buy) | 03/01/2019 | 03/01/2029 | Ordinary Shares(1) | 20,000 | $16.87 | D | |
| Stock Option (Right to Buy) | 02/03/2020 | 02/03/2030 | Ordinary Shares(1) | 3,100 | $18.39 | D | |
| Stock Option (Right to Buy) | 01/04/2021 | 01/04/2031 | Ordinary Shares(1) | 3,100 | $5.03 | D | |
| Stock Option (Right to Buy) | 07/19/2023 | 07/19/2033 | Ordinary Shares(1) | 50,700 | $1.08 | D | |
| Explanation of Responses: |
| 1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| 2. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. |
| 3. On March 1, 2021, the Reporting Person was granted 10,400 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in four equal installments on each of March 1, 2022, March 1, 2023, March 1, 2024, and March 1, 2025. |
| 4. Not applicable |
| 5. On February 4, 2022, the Reporting Person was granted 25,200 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024, and January 31, 2025. |
| 6. On August 8, 2022, the Reporting Person was granted 25,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in four equal installments on each of August 1, 2023, August 1, 2024, August 1, 2025, and August 1, 2026. |
| 7. On February 1, 2023, the Reporting Person was granted 33,800 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025, and January 31, 2026. |
| 8. On April 1, 2023, the Reporting Person was granted 7,500 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 1, 2024, April 1, 2025, and April 1, 2026. |
| 9. On February 1, 2024, the Reporting Person was granted 110,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026, and January 31, 2027. |
| /s/ Jonathan Provoost | 10/31/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||